Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.

Saved in:
Bibliographic Details
Title: Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
Authors: Bennett, Jason W.1, Yadava, Anjali1 Anjali.Yadava.Civ@mail.mil, Tosh, Donna1, Sattabongkot, Jetsumon2, Komisar, Jack1, Ware, Lisa A.1, McCarthy, William F.3, Cowden, Jessica J.1, Regules, Jason1, Spring, Michele D.1, Paolino, Kristopher1, Hartzell, Joshua D.4, Cummings, James F.1, Richie, Thomas L.5, Lumsden, Joanne1, Kamau, Edwin1, Murphy, Jittawadee1, Lee, Cynthia6, Parekh, Falgunee6, Birkett, Ashley6
Source: PLoS Neglected Tropical Diseases. 2/26/2016, Vol. 10 Issue 2, p1-16. 16p.
Database: Academic Search Ultimate
Description
ISSN:19352727
DOI:10.1371/journal.pntd.0004423